# Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy

> **NCT02381444** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 136 (actual)

## Conditions studied

- Parkinson's Disease (PD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02381444
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-17
- **Primary completion:** 2020-01-07
- **Final completion:** 2020-01-07
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2020-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02381444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02381444, "Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02381444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*